Literature DB >> 35154366

Adult intensive care unit admissions with severe COVID-19 infection following emergency Caesarean section deliveries: A case series.

Sarah Morton1, Holly Lamont1, Natalie Silvey1, Thomas Browning1, Michelle Hayes1, Richard Keays1, Linsey Christie1, Roger Davies1, Suveer Singh1, Chris Lockie1, Alice Sisson1, Marcela Vizcaychipi1,2.   

Abstract

BACKGROUND: UK data suggest 6% of COVID-19 hospital admissions are either currently pregnant or immediately post-partum. However, the current literature suggests that if COVID-19 occurs in pregnancy, or post-partum, symptoms are mostly mild.
METHODS: All COVID-19 admissions to one acute London National Health Service Foundation trust were reviewed since the beginning of the COVID-19 pandemic to 1 May 2020 to establish whether there were any pregnant or immediately post-partum admissions. Data were extracted from hospital electronic records and anonymised. Any patients admitted to adult intensive care unit had their case notes reviewed in detail and comparison made to a local risk-assessment guideline identifying patients at-risk of thromboembolic events or cytokine storms. Local hospital guidelines were followed. Patients admitted to adult intensive care unit gave written consent.
RESULTS: A total of 24 pregnant or immediately post-partum patients with COVID-19 were admitted. Three patients required long adult intensive care unit admissions for severe single-organ respiratory failure after emergency C-sections. Two of these patients required proning (three times and eight times, respectively). All were considered medium risk for thromboembolic events but had rising D-dimers following adult intensive care unit admission, resulting in increased dosing of pharmacological thromboprophylaxis throughout their admission. All were considered low risk for a cytokine storm, and none had any significant cardiovascular or renal involvement. One patient developed a super-imposed fungal lung infection. All three patients developed delirium following cessation of sedation.
CONCLUSION: Pregnant or immediately post-partum women can develop severe COVID-19 symptoms requiring prolonged adult intensive care unit admission. It is likely to be single-organ failure, but patients are at a high risk of a thromboembolic event and delirium. © The Intensive Care Society 2020.

Entities:  

Keywords:  COVID-19; intensive care; post-partum; pregnancy; respiratory failure; thrombosis

Year:  2020        PMID: 35154366      PMCID: PMC8829764          DOI: 10.1177/1751143720947547

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  21 in total

1.  Severe 2009 H1N1 influenza in pregnant and postpartum women in California.

Authors:  Janice K Louie; Meileen Acosta; Denise J Jamieson; Margaret A Honein
Journal:  N Engl J Med       Date:  2009-12-23       Impact factor: 91.245

2.  A snapshot of the Covid-19 pandemic among pregnant women in France.

Authors:  Gilles Kayem; Edouard Lecarpentier; Philippe Deruelle; Florence Bretelle; Elie Azria; Julie Blanc; Caroline Bohec; Marie Bornes; Pierre-François Ceccaldi; Yasmine Chalet; Céline Chauleur; Anne-Gael Cordier; Raoul Desbrière; Muriel Doret; Michel Dreyfus; Marine Driessen; Marion Fermaut; Denis Gallot; Charles Garabédian; Cyril Huissoud; Dominique Luton; Olivier Morel; Franck Perrotin; Olivier Picone; Patrick Rozenberg; Loïc Sentilhes; Jeremy Sroussi; Christophe Vayssière; Eric Verspyck; Alexandre J Vivanti; Norbert Winer; Vivien Alessandrini; Thomas Schmitz
Journal:  J Gynecol Obstet Hum Reprod       Date:  2020-06-04

3.  Anxiety, Depression and Post Traumatic Stress Disorder after critical illness: a UK-wide prospective cohort study.

Authors:  Robert Hatch; Duncan Young; Vicki Barber; John Griffiths; David A Harrison; Peter Watkinson
Journal:  Crit Care       Date:  2018-11-23       Impact factor: 9.097

4.  Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections.

Authors:  David A Schwartz; Ashley L Graham
Journal:  Viruses       Date:  2020-02-10       Impact factor: 5.048

5.  Severe COVID-19 during Pregnancy and Possible Vertical Transmission.

Authors:  Maria Claudia Alzamora; Tania Paredes; David Caceres; Camille M Webb; Luis M Valdez; Mauricio La Rosa
Journal:  Am J Perinatol       Date:  2020-04-18       Impact factor: 1.862

6.  Coronavirus disease 2019 in pregnancy: early lessons.

Authors:  Noelle Breslin; Caitlin Baptiste; Russell Miller; Karin Fuchs; Dena Goffman; Cynthia Gyamfi-Bannerman; Mary D'Alton
Journal:  Am J Obstet Gynecol MFM       Date:  2020-03-27

7.  Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission.

Authors:  Patrick J Lillie; Anda Samson; Ang Li; Kate Adams; Richard Capstick; Gavin D Barlow; Nicholas Easom; Eve Hamilton; Peter J Moss; Adam Evans; Monica Ivan; Yusri Taha; Christopher J A Duncan; Matthias L Schmid
Journal:  J Infect       Date:  2020-02-28       Impact factor: 6.072

8.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.

Authors:  Tao Chen; Di Wu; Huilong Chen; Weiming Yan; Danlei Yang; Guang Chen; Ke Ma; Dong Xu; Haijing Yu; Hongwu Wang; Tao Wang; Wei Guo; Jia Chen; Chen Ding; Xiaoping Zhang; Jiaquan Huang; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  BMJ       Date:  2020-03-26

9.  Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome.

Authors:  Shell F Wong; Kam M Chow; Tse N Leung; Wai F Ng; Tak K Ng; Chi C Shek; Pak C Ng; Pansy W Y Lam; Lau C Ho; William W K To; Sik T Lai; Wing W Yan; Peggy Y H Tan
Journal:  Am J Obstet Gynecol       Date:  2004-07       Impact factor: 8.661

10.  A systematic scoping review of COVID-19 during pregnancy and childbirth.

Authors:  Farida Elshafeey; Rana Magdi; Nader Hindi; Mohamed Elshebiny; Nourhan Farrag; Shahd Mahdy; Mohamed Sabbour; Sara Gebril; Mohamed Nasser; Menna Kamel; Abdelrahman Amir; Moataz Maher Emara; Ashraf Nabhan
Journal:  Int J Gynaecol Obstet       Date:  2020-05-17       Impact factor: 4.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.